钱江生化：生物农药原药及制剂退区入园搬迁项目已具备试运营条件

Core Viewpoint - The company announced that its wholly-owned subsidiary, Qichao Biotechnology, has completed the construction of a biopesticide raw material and formulation relocation project, which is now ready for trial operation [1] Group 1: Project Details - The project focuses on the research and production of gibberellin series raw materials and formulations, as well as new environmentally friendly pesticide formulation products [1] - Upon reaching full production capacity, the project is expected to achieve an annual output of 3,261 tons of raw material formulations and 20 million tablets [1]